-
Product Insights
Next Generation Sequencing (NGS) Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Next Generation Sequencing (NGS) Tests Pipeline Market Overview Next generation sequencing (NGS) refers to high-throughput methods for DNA sequencing that are not Sanger-based. NGS technology has largely superseded Sanger sequencing in academic or genome research and is increasingly being applied in clinical practice. Key Territories ·       The US ·       China ·       Global ·       Europe ·       South Korea Key Regulatory Paths ·       510(k) ·       NMPA ·       PMA ·       CE-IVD ·       CLIA Leading Companies ·       4bases SA ·       AccuraGen Inc ·       ACT...
-
Sector Analysis
Next Generation Sequencing Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Next Generation Sequencing (NGS) Tests Market Report Overview The Next Generation Sequencing (NGS) tests market size was valued at $41.9 million in 2022. Next generation sequencing (NGS), or massively parallel sequencing, refers to high-throughput methods for DNA sequencing that are not Sanger-based, based on clonally amplified DNA templates or single DNA molecules rather than electrophoretic separation of chain-termination products produced in individual sequencing reactions. The following are some of the key highlights of the next generation sequencing market are: NGS...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.